Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001002470 | SCV000290950 | likely benign | Arterial tortuosity syndrome | 2024-01-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001798741 | SCV000317888 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2015-04-20 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Eurofins Ntd Llc |
RCV000338554 | SCV000333791 | benign | not specified | 2015-08-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000338554 | SCV000514668 | benign | not specified | 2015-07-29 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ce |
RCV000585432 | SCV000693059 | uncertain significance | not provided | 2017-07-01 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001002470 | SCV001160418 | likely benign | Arterial tortuosity syndrome | 2019-04-25 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000338554 | SCV001339252 | likely benign | not specified | 2024-01-15 | criteria provided, single submitter | clinical testing | Variant summary: SLC2A10 c.674G>A (p.Arg225His) results in a non-conservative amino acid change located in the Major facilitator superfamily domain (IPR020846) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0015 in 250864 control chromosomes, including 3 homozygotes, predominantly at a frequency of 0.0089 within the African or African-American subpopulation in the gnomAD database. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 5.6 fold of the estimated maximal expected allele frequency for a pathogenic variant in SLC2A10 causing Arterial Tortuosity Syndrome phenotype (0.0016), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. c.674G>A has been reported in the literature in at least one homozygous individual affected with Arterial Tortuosity Syndrome (e.g., Beyens_2018). These report(s) do not provide unequivocal conclusions about association of the variant with Arterial Tortuosity Syndrome. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 29323665). ClinVar contains an entry for this variant (Variation ID: 241606). Based on the evidence outlined above, the variant was classified as likely benign. |
CHEO Genetics Diagnostic Laboratory, |
RCV001798741 | SCV002043616 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2019-05-01 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000338554 | SCV001807502 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000585432 | SCV001967981 | likely benign | not provided | no assertion criteria provided | clinical testing |